Our experience with bevacizumab in first-line treatment of epithelial ovarian cancer. Onkologija [Internet]. 2020 May 12 [cited 2026 Sep. 3];24(1):20-4. Available from: https://www.revijaonkologija.si/Onkologija/article/view/441